1Cell.Ai Inc.

1Cell.Ai Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

1Cell.Ai Inc. is a Precision Oncology Liquid Biopsy Diagnostics Company focused on developing the 1st-in-Class, Circulating Tumor Cell (CTC)-based, Single-Cell Multi-omics Lab Developed Tests for applications in clinical cancer care & early-stage clinical trials for Biotech/Pharma companies. 1Cell.Ai Inc. is a joint venture between two companies with innovative technologies: Actorius Innovations and Research Pvt Ltd, a leading provider of CTC Tests in India, and Indx.ai, a Silicon Valley based innovative software company specialising in Multi-omics Biomarker Data Analytics.

Company Details

Employees
167
Founded
-
Address
209, B Wing, Go Square,, Aundh-Hinjewadi Road,wakad,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
IT Consulting.
HQ
Pune , Maharashtra
Looking for a particular 1Cell.Ai Inc. employee's phone or email?

1cell.ai Inc. Questions

News

1Cell.Ai, Formerly OneCell Diagnostics, Launches OncoIncytes Integrating Multi-Modal Data for Precision Oncology - PR Newswire

1Cell.Ai, Formerly OneCell Diagnostics, Launches OncoIncytes Integrating Multi-Modal Data for Precision Oncology PR Newswire

Seeing What Can’t Be Seen - Inside Precision Medicine

Seeing What Can’t Be Seen Inside Precision Medicine

From data to therapy: emerging tech driving cancer drug discovery - Drug Target Review

From data to therapy: emerging tech driving cancer drug discovery Drug Target Review

AccuGenomics and 1Cell.Ai Partner to Bring Ultra-Sensitive Liquid Biopsy Testing Across Asia, with Plans for U.S. Expansion - PR Newswire

AccuGenomics and 1Cell.Ai Partner to Bring Ultra-Sensitive Liquid Biopsy Testing Across Asia, with Plans for U.S. Expansion PR Newswire

Rx Rundown: Sanofi, Regeneron, Havas and more - Medical Marketing and Media

Rx Rundown: Sanofi, Regeneron, Havas and more Medical Marketing and Media

As AI Dawns in Precision Oncology, 2025 Expected To Be a ‘Turning Point’ - BioSpace

As AI Dawns in Precision Oncology, 2025 Expected To Be a ‘Turning Point’ BioSpace

AI and the future of genomics - TechTarget

AI and the future of genomics TechTarget

New smartphone battery platform targets AI workloads with high discharge capability - EE World Online

New smartphone battery platform targets AI workloads with high discharge capability EE World Online

From Blurry to 4K DNA: Dante Omics AI, Rockefeller University, Giunta Lab and Global Partners Assemble the Most Complete Genome for the RPE-1 Cell Line – the Standard for Complex Cell Engineering Experiments - Business Wire

From Blurry to 4K DNA: Dante Omics AI, Rockefeller University, Giunta Lab and Global Partners Assemble the Most Complete Genome for the RPE-1 Cell Line – the Standard for Complex Cell Engineering Experiments Business Wire

Rett syndrome discovery could lead to better treatments - Drug Target Review

Rett syndrome discovery could lead to better treatments Drug Target Review

Novartis licenses innovative treatment for Huntington’s disease - Drug Target Review

Novartis licenses innovative treatment for Huntington’s disease Drug Target Review

E. coli alters ribosomes to survive antibiotic treatment - Drug Target Review

E. coli alters ribosomes to survive antibiotic treatment Drug Target Review

Multi-omic approach classifies biomarkers for paediatric sepsis - Drug Target Review

Multi-omic approach classifies biomarkers for paediatric sepsis Drug Target Review

Researchers discover compound that could treat Chagas disease - Drug Target Review

Researchers discover compound that could treat Chagas disease Drug Target Review

Lung fibrosis in mice successfully reversed by scientists - Drug Target Review

Lung fibrosis in mice successfully reversed by scientists Drug Target Review

Synthetic antibodies show efficacy against bunyaviruses, study finds - Drug Target Review

Synthetic antibodies show efficacy against bunyaviruses, study finds Drug Target Review

New strategy developed to speed up drug discovery process - Drug Target Review

New strategy developed to speed up drug discovery process Drug Target Review

Protein sequencing method could transform biological research - Drug Target Review

Protein sequencing method could transform biological research Drug Target Review

Short peptides discovery could lead to new treatments for Alzheimer’s - Drug Target Review

Short peptides discovery could lead to new treatments for Alzheimer’s Drug Target Review

Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism - Science | AAAS

Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism Science | AAAS

China's Direct Genomics Unveils New Targeted NGS System Based on Helicos Tech for Clinical Use - GenomeWeb

China's Direct Genomics Unveils New Targeted NGS System Based on Helicos Tech for Clinical Use GenomeWeb

T-helper-1-cell cytokines drive cancer into senescence - Nature

T-helper-1-cell cytokines drive cancer into senescence Nature

Top 1Cell.Ai Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant